Concepedia

Wei Deng

WD

Statistics

Publications

6

Citations

99

H-Index

6

Active since

2022

Affiliations

Guangzhou University of Chinese Medicine(Current)

First Affiliated Hospital of Guangzhou University of Chinese Medicine

Wei Deng is an author at Guangzhou University of Chinese Medicine specializing in pharmacology, bone resorption inhibition, and medicine.

Publications per year

2022–2024

6

Publications

6

Corylifol A suppresses osteoclastogenesis and alleviates ovariectomy-induced bone loss via attenuating ROS production and impairing mitochondrial function

HaiShan Li, Wei Deng, Jiamin Yang et al. · Biomedicine & Pharmacotherapy · 2024 · 24 citations · Full text

Medicine, Cell Biology, Pharmacology +17

Isoimperatorin attenuates bone loss by inhibiting the binding of RANKL to RANK

HaiShan Li, Wei Deng, Qiuli Qin et al. · Biochemical Pharmacology · 2023 · 22 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Dehydromiltirone inhibits osteoclast differentiation in RAW264.7 and bone marrow macrophages by modulating MAPK and NF-κB activity

Wei Deng, YanBo Huang, HaiShan Li et al. · Frontiers in Pharmacology · 2022 · 15 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Isoliensinine suppresses bone loss by targeted inhibition of RANKL-RANK binding

Wei Deng, HaiShan Li, YongXian Li et al. · Biochemical Pharmacology · 2023 · 13 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Panax notoginseng saponins inhibits oxidative stress- induced human nucleus pulposus cell apoptosis and delays disc degeneration in vivo and in vitro

Danqing Guo, Miao Yu, Huizhi Guo et al. · Journal of Ethnopharmacology · 2023 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

1–5 of 6